Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 230-049-5 | CAS number: 6925-69-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Justification for type of information:
- data is from experimental report
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guideline 402 (Acute Dermal Toxicity)
- Principles of method if other than guideline:
- To assess the toxicological profile of test chemical on application as a single semi-occlusive dermal application to rats
- GLP compliance:
- yes
Test material
- Reference substance name:
- 12H-phthaloperin-12-one
- EC Number:
- 230-049-5
- EC Name:
- 12H-phthaloperin-12-one
- Cas Number:
- 6925-69-5
- Molecular formula:
- C18H10N2O
- IUPAC Name:
- 12H-phthaloperin-12-one
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Name of test material : 12H-phthaloperin-12-one
- Common name : C.I. Solvent Orange 60
- Molecular formula : C18H10N2O
- Molecular weight : 270.29 g/mol
- Smiles notation : O=C1N2c3c4c(cccc4N=C2c2ccccc12)ccc3
- InChl : 1S/C18H10N2O/c21-18-13-8-2-1-7-12(13)17-19-14-9-3-5-11-6-4-10-15(16(11)14)20(17)18/h1-10H
- Substance type : Organic
- Physical state : Solid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Details on test animals or test system and environmental conditions:
- Details on test animals
Sex: females, Females were nulliparous and non-pregnant
Source : Geniron Biolabs Pvt. Ltd., Bengaluru, India
Age at treatment: 10 to 12 weeks
Body weight range at treatment: Females: 235.18 to 238.33 g
Identification :By rat accession number. Identification of individual rats is by cage card and crystal violet colour body markings. The temporary body marking during acclimatization period was done with crystal violet. The rat accession numbers were allotted during the course of the study and was included in raw data and reported.
Housing: Animals were housed individually in standard polysulfone cages (Size: L 425 x B 266 x H 185 mm), with stainless steel top grill having facilities for pelleted food and drinking water in polycarbonate bottle. Steam sterilized corn cob was used and changed once a week along with the cage.
Diet:Hypro Rat & Mice pellet feed, manufactured at Sangli, Maharashtra, was provided to ad libitum to animals
Water: Purified water in polycarbonate bottles with stainless steel sipper tubes was provided ad libitum
Acclimatization:After physical examination for good health and suitability for experiment, the rats were acclimatized for six, eight, twelve and fourteen days before treatment for dose range finding and main study respectively under standard laboratory conditions. Animals were observed once daily during acclimatization period.
Environmental Conditions:
Temperature: 22 to 25°C
Relative humidity: 66 to 68%
Air changes: air conditioned with adequate fresh air supply (12.4 air changes/hour)
Photoperiod (hrs dark / hrs light): 12 hours light and 12 hours dark cycle
In Life dates: Start: 26 June 2018 , End: 11 September 2018
Test system
- Type of coverage:
- semiocclusive
- Preparation of test site:
- clipped
- Vehicle:
- unchanged (no vehicle)
- Controls:
- not specified
- Amount / concentration applied:
- Dose range finding study:200 (0.20 mL/kg body weight), 1000 (1 mL/kg body weight) and 2000(1.99 mL/kg body weight)
Main Study: 2000 mg/kg - Duration of treatment / exposure:
- 24 hours
- Observation period:
- 14 days
- Number of animals:
- 5 females (3 females for dose range finding study followed by 2 females for main study)
- Details on study design:
- TEST SITE
- Area of exposure: clipped skin of the torso
- % coverage: 10% of the body surface of the animal (semi-occlusive).
- Type of wrap if used: The area of application was covered with cotton gauze (size: Females: 8 x 5 cm of 6 ply) and it was secured in position by adhesive tape wound around the torso
REMOVAL OF TEST SUBSTANCE
- Washing (if done): yes
- Time after start of exposure: After the 24 hours contact period, the dressing was removed and the applied area was washed with deionized water and wiped dry using clean towels
OBSERVATION TIME POINTS
(indicate if minutes, hours or days) : All the rats were observed for clinical signs of toxicity and mortality for 14 days post application. In addition, the treatment site was observed at 24, 48 and 72 hours after removal of test item using the Draize criteria
SCORING SYSTEM:
- Method of calculation: Draize method
Results and discussion
In vivo
Results
- Irritation parameter:
- overall irritation score
- Basis:
- mean
- Time point:
- 72 h
- Score:
- 0
- Reversibility:
- not specified
- Remarks on result:
- no indication of irritation
- Irritant / corrosive response data:
- No skin irritation was observed.
Any other information on results incl. tables
TABLE 1. Individual body weight, body weight changes and pre-terminal deaths
Group and Dose (mg/kg body weight) |
Rat No. |
S e x |
Body weight (g) |
Pre-terminal deaths |
||||
Initial (Day 1 - at treatment) |
8th day |
Weight change (day 8 – Initial) |
15th day |
Weight change (day 15 – Initial) |
||||
G1 and 200 DRF |
Rw283 |
F |
235.18 |
242.68 |
7.50 |
248.19 |
13.01 |
0 |
G2 and 1000 DRF |
Rw284 |
F |
238.33 |
245.45 |
7.12 |
251.67 |
13.34 |
0 |
G3 and 2000 DRF |
Rw285 |
F |
238.16 |
244.73 |
6.57 |
249.14 |
10.98 |
0 |
G3 and 2000 Main study |
Rw286 |
F |
230.34 |
236.59 |
6.25 |
241.08 |
10.74 |
0 |
Rw287 |
F |
234.62 |
242.93 |
8.31 |
247.63 |
13.01 |
0 |
DRF: Dose Range Finding F: Female
APPENDIX 1. Individual test item application, clinical signs, skin reactionand necropsy findings
Dose range finding study
Group & Dose (mg/kg body weight) |
Date and time of application |
Rat Number |
S e x |
Initial Bwt (g) |
Quantity (mL) applied |
Observations and skin reaction |
||||||||||||||||
Days |
||||||||||||||||||||||
1 |
2 |
3 |
4 |
5 |
||||||||||||||||||
30 min |
1 h # |
2 h # |
3 h # |
4 h # |
5 h # |
6 h # |
* |
Er @ |
Ed @ |
* |
Er @ |
Ed @ |
* |
Er @ |
Ed @ |
|||||||
G1 and 200 DRF |
11 April 2018 and 10.55 AM |
Rm8907 |
F |
223.58 |
0.04 |
N |
N |
N |
N |
N |
N |
N |
N |
N |
0 |
0 |
N |
0 |
0 |
N |
0 |
0 |
Group & Dose (mg/kg body weight) |
Rat Number |
S e x |
Observation |
Necropsy findings |
|||||||||
Days |
|||||||||||||
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
||||
G1 and 200 DRF |
Rm8907 |
F |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
NAD |
F: Female N: Normal h: hour min: minutes NAD: No abnormality detected Er: Erythema Ed: Edema
Score 0: No Erythema / Edema
*: Clinical signs; @: Skin scoring as per Draize method (approximately 24, 48 and 72 hours) after test patch removal
APPENDIX 2 contd. Individual test item application, clinical signs, skin reaction and necropsy findings
Dose range finding study
Group & Dose (mg/kg body weight) |
Date and time of application |
Rat Number |
S e x |
Initial Bwt (g) |
Quantity (mg) applied |
Observations and skin reaction |
|||||||||||||
Days |
|||||||||||||||||||
1 |
2 |
3 |
4 |
||||||||||||||||
30 min |
1 h |
2 h |
3 h |
4 h |
5 h |
6 h |
* |
Er @ |
Ed @ |
* |
Er @ |
Ed@ |
|||||||
G1- DRF and 200
|
03 July 2018 and 11.36 AM |
Rw283 |
F |
235.18 |
47 |
N |
N |
N |
N |
N |
N |
N |
N |
N |
0 |
0 |
N |
0 |
0 |
Group & Dose (mg/kg body weight) |
Animal Number |
S e x |
Observation/ Days |
Necropsy findings |
||||||||||||||||||||||||||||||
5 |
|
|||||||||||||||||||||||||||||||||
* |
Er @ |
Ed @ |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
||||||||||||||||||||||
G1- DRF and 200
|
Rw283 |
F |
N |
0 |
0 |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
NAD |
F: Female N: Normal h: hour min: minutes NAD: No abnormality detected Er: Erythema Ed: Edema
Score 0: No Erythema / Edema
*: Clinical signs; @: Skin scoring as per Draize method (approximately 24, 48 and 72 hours) after test patch removal
APPENDIX 2 contd. Individual test item application, clinical signs, skin reaction and necropsy findings
Dose range finding study
Group & Dose (mg/kg body weight) |
Date and time of application |
Rat Number |
S e x |
Initial Bwt (g) |
Quantity (mg) applied |
Observations and skin reaction |
|||||||||||||
Days |
|||||||||||||||||||
1 |
2 |
3 |
4 |
||||||||||||||||
30 min |
1 h |
2 h |
3 h |
4 h |
5 h |
6 h |
* |
Er @ |
Ed @ |
* |
Er @ |
Ed @ |
|||||||
G2- DRF and 1000
|
05 July 2018 and 11.56 AM |
Rw284 |
F |
238.33 |
238 |
N |
N |
N |
N |
N |
N |
N |
N |
N |
0 |
0 |
N |
0 |
0 |
Group & Dose (mg/kg body weight) |
Animal Number |
S e x |
Observation/ Days |
Necropsy findings |
||||||||||||||||||||||||||||||
5 |
|
|||||||||||||||||||||||||||||||||
* |
Er @ |
Ed @ |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
||||||||||||||||||||||
G2- DRF and 1000
|
Rw284 |
F |
N |
0 |
0 |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
NAD |
F: Female N: Normal h: hour min: minutes NAD: No abnormality detected Er: Erythema Ed: Edema
Score 0: No Erythema / Edema
*: Clinical signs; @: Skin scoring as per Draize method (approximately 24, 48 and 72 hours) after test patch removal
APPENDIX 2 contd. Individual test item application, clinical signs, skin reaction and necropsy findings
Main study
Group & Dose (mg/kg body weight) |
Date and time of application |
Rat Number |
S e x |
Initial Bwt (g) |
Quantity (mg) applied |
Observations and skin reaction |
|||||||||||||
Days |
|||||||||||||||||||
1 |
2 |
3 |
4 |
||||||||||||||||
30 min |
1 h |
2 h |
3 h |
4 h |
5 h |
6 h |
* |
Er @ |
Ed @ |
* |
Er @ |
Ed @ |
|||||||
G3- Main and 2000
|
12 July 2018 and 11.41 AM to 11.42 AM |
Rw286 |
F |
230.34 |
461 |
N |
N |
N |
N |
N |
N |
N |
N |
N |
0 |
0 |
N |
0 |
0 |
Rw287 |
F |
234.62 |
469 |
N |
N |
N |
N |
N |
N |
N |
N |
N |
0 |
0 |
N |
0 |
0 |
Group & Dose (mg/kg body weight) |
Animal Number |
S e x |
Observation/ Days |
Necropsy findings |
||||||||||||||||||||||||||||||
5 |
|
|||||||||||||||||||||||||||||||||
* |
Er @ |
Ed @ |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
||||||||||||||||||||||
G3- Main and 2000
|
Rw286 |
F |
N |
0 |
0 |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
NAD |
||||||||||||||||||
Rw287 |
F |
N |
0 |
0 |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
F: Female N: Normal h: hour min: minutes NAD: No abnormality detected Er: Erythema Ed: Edema
Score 0: No Erythema / Edema
*: Clinical signs; @: Skin scoring as per Draize method (approximately 24, 48 and 72 hours) after test patch removal
Applicant's summary and conclusion
- Interpretation of results:
- other: not irritating
- Conclusions:
- There was no skin reaction observed at test item applied area. The mean erythema and edema scores were 0.0 at all observation times. Hence, it was concluded that test chemical was Non-Irritating to the skin of Wistar rats under the experimental conditions tested and classified as “Category-Not Classified” as per CLP Classification.
- Executive summary:
The study designed and conducted to determine the dermal reaction profile of test chemical in Wistar rats. The study was performed as per OECD Guidelines 402 and complying to the GLP procedures.
The test chemical was tested in 5 females (3 females for dose range finding study followed by 2 females for main study) Wistar rats at the doses of 200, 1000 and 2000 mg/kg body weight.
Based on the individual body weight, the undiluted test item at the doses of 200 (0.20 mL/kg body weight), 1000 (1 mL/kg body weight) and 2000(1.99 mL/kg body weight) - based on the density of the test item1.004 g/cm3 was applied directly to the clipped skin of the animal to cover about 10% of the body surface of the animal (semi-occlusive). The area of application was covered with cotton gauze (size: Females: 8 x 5 cm of 6 ply) and it was secured in position by adhesive tape wound around the torso. The test item contact period with the skin was for 24 hours. After the 24 hours contact period, the dressing was removed and the applied area was washed with deionized water and wiped dry using clean towels. All the rats were observed for clinical signs of toxicity and mortality for 14 days post application. In addition, the treatment site was observed at 24, 48 and 72 hours after removal of test item using the Draize criteria. There were no clinical signs of toxicity and mortality. There was no skin reaction observed at test item applied area. Body weight was measured on days 1, 8 and 15 and all rats gained weight during experimental period. At the end of observation period, all surviving animals were euthanized and subjected to necropsy. There were no abnormalities detected at the necropsy.
There was no skin reaction observed at test item applied area. The mean erythema and edema scores were 0.0 at all observation times. Hence, it was concluded that the test chemical was Non-Irritating to the skin of Wistar rats under the experimental conditions tested and classified as “Category-Not Classified” as per CLP Classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
